BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3920370)

  • 1. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
    Lauder I; Bird CC; Child JA; Grigor I
    J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between immunological phenotype and karyotype in malignant lymphoma.
    Levine EG; Arthur DC; Gajl-Peczalska KJ; LeBien TW; Peterson BA; Hurd DD; Bloomfield CD
    Cancer Res; 1986 Dec; 46(12 Pt 1):6481-8. PubMed ID: 3096564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas.
    Kaleem Z; Zehnbauer BA; White G; Zutter MM
    Am J Clin Pathol; 2000 Mar; 113(3):399-405. PubMed ID: 10705821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
    Norton AJ; Isaacson PG
    Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic phenotype in 30 patients with diffuse large-cell lymphoma.
    Warnke R; Miller R; Grogan T; Pederson M; Dilley J; Levy R
    N Engl J Med; 1980 Aug; 303(6):293-300. PubMed ID: 6770268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic expression of non-Hodgkin's lymphomas in China.
    Xu LZ; Tu LY; Liu YF; Hsu SM; Qiu BS; Li ZX
    J Natl Cancer Inst; 1984 Sep; 73(3):635-8. PubMed ID: 6236322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
    Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotypic and genotypic marker in malignant lymphomas: cellular origin of Hodgkin's disease and malignant histiocytosis as well as implications for classifying T-cell and B-cell lymphomas].
    Stein H; Gerdes J
    Verh Dtsch Ges Pathol; 1986; 70():127-51. PubMed ID: 3548121
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of IgD on B cell malignancy. An immunopathological study of 50 cases.
    Mori S; Hagiwara S; Kodo H; Mohri N
    Acta Pathol Jpn; 1986 Oct; 36(10):1429-40. PubMed ID: 3099539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Tac antigen in B cell lymphomas.
    Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
    Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine needle aspiration cytology and immunocytochemistry in the diagnosis of lymphoid lesions of the thyroid gland.
    Tani E; Skoog L
    Acta Cytol; 1989; 33(1):48-52. PubMed ID: 2521756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Most null large cell lymphomas are B lineage neoplasms.
    Cleary ML; Trela MJ; Weiss LM; Warnke R; Sklar J
    Lab Invest; 1985 Nov; 53(5):521-5. PubMed ID: 3932778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface marker identification of small cleaved follicular center cell lymphomas with a highly favorable prognosis.
    Rudders RA; Ahl ET; Delellis RA; Bernstein S; Begg CB
    Cancer Res; 1982 Jan; 42(1):349-53. PubMed ID: 7053861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mantle-zone lymphoma. A pattern produced by lymphomas of more than one cell type.
    Harris NL; Bhan AK
    Am J Surg Pathol; 1985 Dec; 9(12):872-82. PubMed ID: 2933967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.